Transplant Genomics' Series B Round

Transplant Genomics raised a round of funding on September 06, 2018.

Transplant Genomics is a molecular diagnostics company committed to improving organ transplant outcomes through tests that detect early signs of graft injury, differentiate among causes and enable opt…

Articles about Transplant Genomics' Series B Round: